From the Editor

Bewitched, bothered, and bedeviled

By Carren Bersch

Our already-busy New Year has had every Devil-ish detail of it splashed across not just entertainment TV but also scores of news outlets and newspapers:

  • "Balloon Boy’s" dad spent his first night of 90 in jail — a real reality show.
  • Mark McGwire finally admitted to steroid use after almost five years.
  • Tiger Woods’ private life unravelled publicly in the blink of an eye.
  • Mariah Carey’s explanation of her public inebriation became 24/7 news.
  • Kate Gosselin got new $7,000 hair extensions and a new TV show.
  • Simon Cowell is leaving "American Idol" for his own "X Factor."

When the Devil is in the details, we get fed the wrong kinds of details. Give me boring facts of any healthcare topic over the Sheens’ marriage-on-the-rocks, another Kardashian exposé, or pro-sports stars’ indiscretions with guns and/or girls.

Did you know, for example, about The Joint Commission’s decision to negate the active patient-involvement step prior to blood sample collection? Last month, MLO Editorial Advisory Board Member Dennis Ernst wrote of his concerns about the lack of patient ID confirmation by a patient or a third party; 74% of healthcare workers who responded to his Center for Phlebotomy’s survey admitted having found ID bracelets attached to the wrong patient. A decade ago, attention to detail was needed to put a stop to dreadful mistakes in hospitals when patients’ IDs were somehow switched or were incomplete. Only four years ago, a study at the West Los Angeles VA Medical Center compared wristband identification errors for 712 hospitals. Phlebotomists checked patient wristbands on 2,463,727 occasions, finding 67,289 errors. The researchers found 33,308 patient wristbands missing entirely, 49.5% of errors; wristbands with incomplete data, 7.5%; erroneous data, 8.6%; illegible data, 5.7%; and patients wearing wristbands with another patient’s ID info, 0.5% (www.endonurse.com/articles/patient_safety/596_641feat4.html).

Did you hear, by chance, about Oswaldo Juarez? He has XXDR-TB — a brand-new strain of TB and this country’s first case of a contagious, aggressive, extremely drug-resistant (XXDR) TB, so rare that only a handful of people worldwide are thought to have had it. A Peruvian here to study English, Juarez underwent three months of futile treatment in a Florida hospital, then in December 2007, he was sent to A.G. Holley State Hospital, the nation’s last-standing TB quarantine sanitarium in Lantana, FL, now managing new and virulent forms of TB. In July 2009, 19 months after checking in, Juarez was released (www.pediatricsupersite.com/view.aspx?rid=59864), having cost Florida taxpayers about $500,000.

Did you read that the ACLU, scientists, and cancer patients sued the U.S. Patent and Trademark Office and Myriad Genetics (a company holding patents to two human genes linked to breast and ovarian cancer)? Civil libertarians argue the sort of patent granted to Myriad could be used to slow medical advancements by limiting access to crucial research tools and data. A complicated situation, but one seemingly not important enough to garner front page news or prompt a TV debate. Even the late author Michael Crichton wrote a 2007 commentary (www.nytimes.com/2007/02/13/opinion/13crichton.html), but his remarks likely were overshadowed by a celebrity romance, scandal, or red-carpet sideshow taking place that day.

News about patient ID confirmation, XXDR-TB and other strains of TB, and gene patents affects all of us, yet these topics cannot compete when put up against the 24/7 celebrity banter that passes as "news." If the Devil is in the details, we need to have a talk. He … or she (?) … is, as usual, leading people down the wrong path.


cbersch@nelsonpub.com

 

 

 

 

Make lab services available — minister - New Vision

Report finds low morale, lack of expertise at St. John's, N.L., lab - Winnipeg Free Press

Denver Health saves millions using Toyota efficiency principles - Denver Post

NeoGenomics Reports Second Quarter 2010 Results - MarketWatch (press release)

IRIS International to Acquire CLIA Certified Laboratory - MarketWatch (press release)

Bernstein Liebhard LLP Announces Filing of Action on Behalf of Investors in ... - MarketWatch (press release)

RICHARDSON v. DEBORAH HEART & LUNG CENTER - Leagle.com

Halfpenny Technologies Partners With HT Systems To Provide - Healthcare Technology Online (press release)

Instrumentation Laboratory Receives FDA Clearance for New Automated Total ... - PR-USA.net (press release)

Clarient Achieves Profitability and Continues Growth Trajectory in the Second ... - MarketWatch (press release)

 

 

Search more than 3,500 tests, equipment, products, and services for the clinical lab market with company cross references